Activities of Horst SCHNELLHARDT related to 2008/0142(COD)
Plenary speeches (1)
Patients’ rights in cross-border healthcare (debate)
Amendments (9)
Amendment 138 #
Council position
Article 1 – paragraph 3 – point c a (new)
Article 1 – paragraph 3 – point c a (new)
(ca) sales of medicinal products and medical devices over the Internet.
Amendment 141 #
Council position
Article 3 – paragraph 1 – point a
Article 3 – paragraph 1 – point a
(a) "healthcare" means health services provided by health professionals to patients to assess, maintain or restore their state of health, including the prescription, dispensation and provision of medicinal products and medical devices if these activities are performed in a Member State where the services are provided by members of the health professions under the appropriate professional title;
Amendment 150 #
Council position
Article 4 – paragraph 2 – point f
Article 4 – paragraph 2 – point f
(f) patients who have received treatment are entitled to a written or electronic medical record of such treatment, and access to at least a copy of this record in conformity with and subject to national measures implementing Union provisions on the protection of personal data, in particular Directives 95/46/EC and 2002/58/EC, without prejudice to the exceptions applicable in the Member States.
Amendment 200 #
Council position
Article 11 – paragraph 2 – introductory part
Article 11 – paragraph 2 – introductory part
(2) In order to facilitate implementationFor the purposes of paragraph 1, the Commission shall adopsupport:
Amendment 201 #
Council position
Article 11 – paragraph 2 – point a
Article 11 – paragraph 2 – point a
(a) no later than…. measuresprocesses at Member State level enabling a health professional to verify the authenticity of the prescription and whether the prescription was issued in another Member State by a member of a regulated health profession who is legally entitled to do so through developing a non-exhaustive list of elements to be included in the prescriptions; *Note to OJ: please insert the date - 18 months after the entry into force of this Directive.
Amendment 203 #
Council position
Article 11 – paragraph 2 – point b
Article 11 – paragraph 2 – point b
(b) guidelines supporting the Member States in developing the interoperability of ePrescriptions; for this purpose it shall draw up guidelines in close collaboration with the Member States;
Amendment 205 #
Council position
Article 11 – paragraph 2 – point c
Article 11 – paragraph 2 – point c
(c) no later than… measuresprocesses at Member State level to facilitate the correct identification of medicinal products or medical devices prescribed in one Member State and dispensed in another, including measures to address patient safety concerns in relation to their substitution in cross-border healthcare where the legislation of the dispensing Member State permits such substitution. The Commission shall consider, inter alia, using the International Non-proprietary Name and the dosage of medicinal products; *Note to OJ: please insert the date - 18 months after the entry into force of this Directive.
Amendment 206 #
Council position
Article 11 – paragraph 2 – point d
Article 11 – paragraph 2 – point d
(d) no later than…* measuresprocesses at Member State level to facilitate the comprehensibility of the information to patients concerning the prescription, and the instructions included therein, on the use of the medicinal products or medical devices. *Note to OJ: please insert the date - 18 months after the entry into force of this Directive.
Amendment 208 #
Council position
Article 11 – paragraph 3
Article 11 – paragraph 3